We are live on
!
Find out more
Natixis Advisors Portfolio holdings
AUM
$71.9B
1-Year Est. Return
28.03%
This Fund
S&P 500
This Quarter
Est. Return
+4.94%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$12.2B
AUM Growth
+$822M
(+7.2%)
Cap. Flow
+$335M
Cap. Flow
% of AUM
2.73%
Top 10 Holdings %
Top 10 Hldgs %
14.79%
Holding
1,100
New
46
Increased
577
Reduced
433
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$28.9M |
| 2 |
Vanguard Value ETF
VTV
|
+$19.9M |
| 3 |
Virtu Financial
VIRT
|
+$18M |
| 4 |
Alcon
ALC
|
+$18M |
| 5 |
Procter & Gamble
PG
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ecolab
ECL
|
+$22.6M |
| 2 |
Clorox
CLX
|
+$15.2M |
| 3 |
Rithm Capital
RITM
|
+$9.88M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$8.85M |
| 5 |
State Street
STT
|
+$8.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.6% |
| 2 | Financials | 15.41% |
| 3 | Healthcare | 12.01% |
| 4 | Consumer Discretionary | 9.48% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Jazz Pharmaceuticals
JAZZ
$15.9B
| $5.57M | 0.05% |
39,092
+9,354
| +31% | +$1.26M |
|
427
Synchrony
SYF
$23.7B
| $5.54M | 0.05% |
159,748
-14,448
| -8% | -$490K |
|
428
T. Rowe Price
TROW
$25B
| $5.53M | 0.05% |
50,370
+1,519
| +3% | +$160K |
|
429
Centene
CNC
$31.3B
| $5.48M | 0.04% |
104,535
+1,238
| +1% | +$66.9K |
|
430
Nutrien
NTR
$32.7B
| $5.47M | 0.04% |
102,375
+63,120
| +161% | +$3.3M |
|
|
TMX
431
DELISTED
Terminix Global Holdings, Inc.
TMX
| $5.46M | 0.04% |
104,822
-13,978
| -12% | -$719K |
|
|
TGNA
432
DELISTED
TEGNA Inc
TGNA
| $5.45M | 0.04% |
359,930
+3,873
| +1% | +$59.7K |
|
433
Labcorp
LH
$24.3B
| $5.45M | 0.04% |
36,700
+1,792
| +5% | +$250K |
|
434
Target
TGT
$62.1B
| $5.44M | 0.04% |
62,841
+7,369
| +13% | +$595K |
|
435
Barclays
BCS
$94.1B
| $5.44M | 0.04% |
729,668
-421,062
| -37% | -$3.33M |
|
436
MGIC Investment
MTG
$6.27B
| $5.43M | 0.04% |
413,004
+8,278
| +2% | +$115K |
|
437
TransUnion
TRU
$14.8B
| $5.39M | 0.04% |
73,380
+196
| +0.3% | +$13.4K |
|
438
IBM
IBM
$202B
| $5.38M | 0.04% |
40,769
+4,089
| +11% | +$537K |
|
439
Ericsson
ERIC
$30.7B
| $5.37M | 0.04% |
565,688
+478,664
| +550% | +$4.64M |
|
440
Amphenol
APH
$188B
| $5.35M | 0.04% |
222,920
-29,744
| -12% | -$716K |
|
441
Euronet Worldwide
EEFT
$3.02B
| $5.34M | 0.04% |
31,735
-7,706
| -20% | -$1.18M |
|
|
SIVB
442
DELISTED
SVB Financial Group
SIVB
| $5.29M | 0.04% |
23,572
-3,722
| -14% | -$861K |
|
443
Allison Transmission
ALSN
$10.1B
| $5.28M | 0.04% |
113,798
+6,000
| +6% | +$272K |
|
444
F5
FFIV
$22.1B
| $5.27M | 0.04% |
36,206
-2,147
| -6% | -$321K |
|
445
NCR Voyix
VYX
$1.06B
| $5.25M | 0.04% |
275,446
-28,296
| -9% | -$526K |
|
446
Spire
SR
$4.92B
| $5.23M | 0.04% |
62,354
-416
| -0.7% | -$34.9K |
|
447
Bankunited
BKU
$3.38B
| $5.19M | 0.04% |
153,880
+12,322
| +9% | +$425K |
|
|
PPLI
448
People Inc
PPLI
$3.1B
| $5.19M | 0.04% |
133,462
-5,086
| -4% | -$203K |
|
|
SBNY
449
DELISTED
Signature Bank
SBNY
| $5.18M | 0.04% |
42,865
-2,390
| -5% | -$296K |
|
450
iShares Floating Rate Bond ETF
FLOT
$10.1B
| $5.18M | 0.04% |
101,668
-16,113
| -14% | -$820K |
|
Similar funds
Natixis Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Natixis Advisors held 1,100 positions worth $12.2B, up 7.2% from $11.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Natixis Advisors's Q2 2019 filing shows 46 new, 577 increased, 433 reduced and 42 closed positions. Its largest new stake was Alcon: 306,725 shares worth $19M. The largest sale was Ecolab, an estimated $22.6M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
- Natixis Advisors's largest Q2 2019 buy was Alcon: 306,725 shares worth $19M.
- Natixis Advisors added most to Vanguard FTSE Developed Markets ETF in Q2 2019, an estimated $28.9M increase.
- Natixis Advisors's biggest Q2 2019 reduction was Ecolab, cutting an estimated $22.6M.
- Natixis Advisors fully exited Clorox in Q2 2019, selling an estimated $15.2M.
- Natixis Advisors's ten largest holdings make up 15% of its $12.2B portfolio in Q2 2019.
- Natixis Advisors opened 46 new positions and closed 42 in Q2 2019.
- Natixis Advisors's portfolio value rose 7.2% quarter-over-quarter to $12.2B.
Based on Natixis Advisors's 13F filing for Q2 2019, filed 12 Aug 2019.